wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30984472-56239001-92C0-4C0B-8582-0719D0DFA415
Q30984472-56239001-92C0-4C0B-8582-0719D0DFA415
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30984472-56239001-92C0-4C0B-8582-0719D0DFA415
Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness.
P2860
Q30984472-56239001-92C0-4C0B-8582-0719D0DFA415
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30984472-56239001-92C0-4C0B-8582-0719D0DFA415
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
528ee41763e4e00768942fcaccce6230bc80d8ca
P2860
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.